Search results
Eight is enough: Meet the latest crop of June enrollees for Notre Dame football
South Bend Tribune· 4 hours ago“I have recruits and parents that (ask) me all the time: ‘Is he going to be behind if he doesn’t...
Make a Midyear Economic Pit Stop
New Jersey Business Magazine· 2 days agoMany business owners nationwide held their collective breath throughout 2023, anticipating the crash of the economy’s much-discussed “hard landing.” Then...
SEVENTEEN, ENHYPEN And TWICE Are K-Pop Acts Pushing 2024’s Unprecedented Touring Growth
Forbes· 2 days agoIn a year that many industry experts predicted would see a slowdown, the concert touring business...
GeTtin' SALTy Episode 30 | Midyear State Legislative Round Up [Podcast]
The National Law Review· 5 days agoNikki, Morgan, and Ryan discuss state revenues to date, significant SALT proposals that have been...
Commentary: You deserve your dream life | Jax Daily Record
Jacksonville Daily Record· 5 days agoIf you’re like me and many professionals, you might find that your New Year’s resolutions have...
Alibaba courts CEOs to start live-streaming on Taobao during 618 shopping festival
South China Morning Post via Yahoo Finance· 3 days agoTaobao launched a new live-streaming service on Wednesday that features business executives looking...
Civilization VII, Black Myth: Wukong and Other Trailers at Summer Game Fest Showcase
CNET· 3 days agoWhile Microsoft, Sony and Nintendo have trended toward their own showcases, with E3 gone Summer Game...
The 10 Best Films of 2024 (So Far)
Consequence of Sound via Yahoo News· 5 days agoWe always need movies. — Liz Shannon Miller Senior Entertainment Editor Editors Note: Check back for all our 2024 Midyear Report coverage, including our...
Travis County to evaluate EMS services outside city limits
KXAN via Yahoo News· 6 days agoOn Tuesday, Travis County Commissioners Court unanimously approved a midyear budget adjustment of...
BridgeBio dwarfism drug increases height in children, beating BioMarin's Voxzogo
FierceBiotech· 6 days agoBridgeBio Pharma has bounced back from the withdrawal of infigratinib in oncology, linking the...